Loading clinical trials...
Loading clinical trials...
A Phase 2, Open-Label, Multi-Center, Randomized Trial To Demonstrate The Pharmacokinetics Of LCP-Tacro™ Tablets Once Daily and Prograf® Capsules Twice Daily In Adult De Novo Kidney Transplant Patients
Conditions
Interventions
Tacrolimus (Tacro™)
Prograf
Locations
1
United States
University of Cincinnati
Cincinnati, Ohio, United States
Start Date
September 1, 2008
Primary Completion Date
February 1, 2010
Completion Date
February 1, 2010
Last Updated
May 19, 2015
NCT06056102
NCT06297343
NCT07237633
NCT06343727
NCT06972069
NCT06314503
Lead Sponsor
Veloxis Pharmaceuticals
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions